Skip to main content
logo
MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.705
-0.075 (-4.21%)
At close: Jan 15, 2026, 4:00 PM EST
1.700
-0.005 (-0.29%)
After-hours: Jan 15, 2026, 4:04 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Collaborative and Other Agreements
28.99M
Log In
Log In
Log In
Log In
Upgrade
Collaborative and Other Agreements Growth
-75.70%
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody-based Therapeutics
17.94M
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody-based Therapeutics Growth
7.25%
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing
9.83M
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing Growth
-29.70%
Log In
Log In
Log In
Log In
Upgrade
Government Agreements
1.56M
Log In
Log In
Log In
Log In
Upgrade
Government Agreements Growth
-19.08%
Log In
Log In
Log In
Log In
Upgrade
Royalty
431.00K
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
58.75M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-61.33%
Log In
Log In
Log In
Log In
Upgrade